Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

類似資料

• Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
  著者:: Rohla, Miklos, 等
  出版事項: (2019)
• Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF (PREvention oF Thromboembolic Events–European Registry in Atrial Fibrillation)
  著者:: Patti, Giuseppe, 等
  出版事項: (2017)
• Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
  著者:: Schnabel, Renate B, 等
  出版事項: (2017)
• Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation
  著者:: Jolanta M. Siller-Matula, 等
  出版事項: (2020-11-01)
• Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
  著者:: Schnabel, Renate B., 等
  出版事項: (2018)